GGrantIndex
← Search

CASEIN KINASE-1 EPSILON AS A NOVEL THERAPEUTIC TARGET AGAINST SMALL CELL LUNG CANCER.

$155,000FY2022Defense Health AgencyDOD

Indian Institute Of Technology Jodhpur

Investigators

View source on USAspending →
CASEIN KINASE-1 EPSILON AS A NOVEL THERAPEUTIC TARGET AGAINST SMALL CELL LUNG CANCER. · GrantIndex